Involvement of the Family Physician in the Care of Chemotherapy-Treated Patients With Cancer: Patients' Perspectives

2014 ◽  
Vol 10 (5) ◽  
pp. 298-305 ◽  
Author(s):  
Eytan Ben-Ami ◽  
Hadar Merom ◽  
Fabienne Sikron ◽  
Jessica Livneh ◽  
Siegal Sadetzki ◽  
...  
Keyword(s):  
Cancer Patients ◽  
Family Physician ◽  
Medical Training ◽  
Comprehensive Care ◽  
Team Members ◽  
Patients With Cancer ◽  
The Family ◽  
Data Point

The authors' data point to a lack of communication between team members and inadequate medical training as major barriers to comprehensive care for chemotherapy-treated patients.

Insufficient involvement of the family physician (FP) in the care of chemotherapy-treated cancer patients: A barrier to comprehensive medical care.

2013 ◽  
Vol 31 (15_suppl) ◽  
pp. e17536-e17536
Author(s):  
Eytan Ben-Ami ◽  
Hadar Merom ◽  
Fabienne Sikron ◽  
Jessica Livneh ◽  
Siegal Sadetzki ◽  
...  
Keyword(s):  
Medical Care ◽  
Cancer Patients ◽  
Day Care ◽  
Medical Training ◽  
Medical Center ◽  
Medical Problems ◽  
Care Clinic ◽  
Team Members ◽  
The Family

e17536 Background: Following advancement in the oncology field, increasing numbers of patients are receiving ambulatory active treatment for prolonged periods of time. Many of these patients suffer from additional comorbidities and require comprehensive medical care. We aimed to assess the perception of cancer patients regarding the role of the FP and the oncologist in their care during times of active cancer treatment. Methods: A survey was conducted among 265 consecutive chemotherapy-treated patients at the day care clinic of the Oncology Institute at Sheba Medical Center in Israel. Results: Median age was 60 years (range 22-86), 184 (69%) were woman and 147 (55%) were Israeli born. All patients belonged to one of four Israeli HMOs, 96% had a regular FP and 70% met with him during the prior month. While 78% of the patients evaluated that their FP had sufficient time to devote to them, only 32% and 27% thought their FP was trained to or wished to treat medical problems occurring while receiving chemotherapy. Yet, a majority of patients (76%) stated that involvement of the FP is important to them. Surprisingly, 85% perceived the oncologist as having enough time to devote to their care and 60% perceived him as being capable of dealing with non-oncological problems. However, only 30% stated that the oncologist communicates with the FP. Accordingly, 72% of the patients stated that in the case of an urgent problem they will turn first to the oncology institute and only 9% will turn to their FP. Indeed, 46% had unscheduled visits to the day care facilities during the prior month. Conclusions: Our data indicate lack communication between team members and inadequate medical training as major barriers for comprehensive medical care for chemotherapy-treated cancer patients. This may adversely affect medical care, decrease satisfaction among physicians and increase unnecessary workload. A change of the current situation requires collaboration between FPs and oncologists at the local and national levels and should include standardization of communication measures as well as implementation of required aspects in educational programs of both specialties.

Assessing the Quantitative and Qualitative Status of the Family Physician Plan from the Perspective of Family Physicians, Health Team Members and Staff Experts

2021 ◽  
Vol 6 (4) ◽  
pp. 308-318
Author(s):  
Mohammad Javad Kabir ◽  
Alireza Heidari ◽  
Rahman Adel ◽  
Zahra Khatirnamani ◽  
◽  
...  
Keyword(s):  
Family Physician ◽  
Family Physicians ◽  
Team Members ◽  
Health Team ◽  
The Family

scholarly journals The Mediating Effect of Depression on the Relationship between Social Support, Spirituality and Burnout in Family Members of Patients with Cancer

2021 ◽  
Vol 18 (4) ◽  
pp. 1727
Author(s):  
Won-Hee Jun ◽  
Kyung-Sook Cha ◽  
Kee-Lyong Lee
Keyword(s):  
Social Support ◽  
Cancer Patients ◽  
Healthcare Providers ◽  
Family Members ◽  
Mediating Effect ◽  
University Hospital ◽  
Patients With Cancer ◽  
The Family ◽  
Negative Effect ◽  
The Relationship

When the treatment process of cancer patients changes to outpatient treatment, the burden on family members increases and they often experience burnout. Burnout not only effects the family members themselves but may also have a negative effect on the health of the cancer patient. Therefore, healthcare providers should evaluate burnout in the family members of cancer patients and actively make efforts towards their burnout management. This study investigated the mediating effect of depression on the relationship between social support, spirituality, and burnout in family members of patients with cancer. Participants were 151 family members of patients with cancer who were receiving chemotherapy as outpatients at a single university hospital in Korea. Data was collected from 2 March to 31 May 2016, using self-reported questionnaires. Collected data was analyzed with t-tests, analysis of variance (ANOVA), Pearson’s correlations, Baron and Kenny’s three-step regression method, and the Sobel test. The participants’ mean burnout was below the median. The participants’ depression partially mediated the relationship of both social support and spirituality on burnout. Strategies to assess depression and strengthen social support and spirituality should be developed to manage burnout in family members’.

scholarly journals The family physician as a primary care consultant – the Mossel Bay experience

2021 ◽  
Vol 13 (1) ◽  
Author(s):  
Klaus B. Von Pressentin ◽  
Kartik S. Naidoo ◽  
Louis S. Jenkins ◽  
Johann Schoevers
Keyword(s):  
Primary Care ◽  
South African ◽  
Nurse Practitioners ◽  
Family Physician ◽  
District Hospital ◽  
District Health ◽  
Team Members ◽  
System A ◽  
District Hospitals ◽  
The Family

The South African family physician (FP) is an expert generalist who has a number of roles to strengthen the district health system. A research study on FPs in district hospitals has previously demonstrated an impact; however, more evidence on impact in primary health care (PHC) is needed. By serving as a consultant for the PHC team, the FP may improve access to care, capacitate team members, enhance comprehensiveness of care, and improve coordination and continuity of care. This report narrates the story of how one of the FPs at a rural district hospital recorded his experience of being a consultant to the PHC team and was able to self-audit the experience. A self-designed audit tool analysed 1000 patient consultations with the FP and enabled a reflection on the coronavirus disease 2019 (COVID-19)-related changes to the consultant role. There was a clear need for FPs to consult patients with complex multi-morbidity and multifaceted psychosocial aspects to their illness, in consultation with their team members. Patients were referred to them by medical officers, other specialists, family medicine registrars, allied healthcare professionals and nurse practitioners. The FP’s ability to strengthen the PHC service outside the district hospital may be enhanced by creating more FP posts at a subdistrict level to support high-quality, team-based primary care in line with the PHC policy directions.

Treatment and secondary prevention of venous thromboembolism in cancer patients

2012 ◽  
Vol 03 (03) ◽  
pp. 121-125
Author(s):  
I. Pabinger ◽  
C. Ay
Keyword(s):  
Clinical Trials ◽  
Venous Thromboembolism ◽  
Cancer Patients ◽  
Oral Anticoagulants ◽  
Factor Xa ◽  
New Oral Anticoagulants ◽  
Phase Iii ◽  
Patients With Cancer ◽  
Potential Use

SummaryCancer is a major and independent risk factor of venous thromboembolism (VTE). In clinical practice, a high number of VTE events occurs in patients with cancer, and treatment of cancerassociated VTE differs in several aspects from treatment of VTE in the general population. However, treatment in cancer patients remains a major challenge, as the risk of recurrence of VTE as well as the risk of major bleeding during anticoagulation is substantially higher in patients with cancer than in those without cancer. In several clinical trials, different anticoagulants and regimens have been investigated for treatment of acute VTE and secondary prophylaxis in cancer patients to prevent recurrence. Based on the results of these trials, anticoagulant therapy with low-molecular-weight heparins (LMWH) has become the treatment of choice in cancer patients with acute VTE in the initial period and for extended and long-term anticoagulation for 3-6 months. New oral anticoagulants directly inhibiting thrombin or factor Xa, have been developed in the past decade and studied in large phase III clinical trials. Results from currently completed trials are promising and indicate their potential use for treatment of VTE. However, the role of the new oral thrombin and factor Xa inhibitors for VTE treatment in cancer patients still has to be clarified in further studies specifically focusing on cancer-associated VTE. This brief review will summarize the current strategies of initial and long-term VTE treatment in patients with cancer and discuss the potential use of the new oral anticoagulants.

Thrombosis in Cancer Patients Treated with Hematopoietic Growth Factors - A Meta-Analysis

1996 ◽  
Vol 75 (02) ◽  
pp. 368-371 ◽  
Author(s):  
T Barbul ◽  
G Finazzi ◽  
A Grassi ◽  
R Marchioli
Keyword(s):  
Cancer Patients ◽  
Case Reports ◽  
Meta Analysis ◽  
Case Series ◽  
Hematopoietic Growth Factors ◽  
Patients With Cancer ◽  
Cytotoxic Treatment ◽  
Pertinent Data ◽  
Thrombotic Complications ◽  
Vascular Occlusions

SummaryHematopoietic colony-stimulating factors (CSFs) are largely used in patients with cancer undergoing cytotoxic treatment to accelerate neutrophil recovery and decrease the incidence of febrile neutropenia. Clinical practice guidelines for their use have been recently established (1), taking into account clinical benefit, but also cost and toxicity. Vascular occlusions have been recently reported among the severe reactions associated with the use of CSFs, in anedoctal case reports (2, 3), consecutive case series (4) and randomized clinical trial (5, 6). However, the role of CSFs in the pathogenesis of thrombotic complications is difficult to ascertain, because pertinent data are scanty and widely distributed over a number of heterogenous investigations. We report here a systematic review of relevant articles, with the aims to estimate the prevalence of thrombosis associated with the use of CSFs and to assess if this rate is significantly higher than that observed in cancer patients not receiving CSFs.

COVID-19 in patients suffering from Cancer: Review article

2020 ◽  
Vol 11 (SPL1) ◽  
pp. 1494-1499
Author(s):  
Shahid Ahmad Siddiqui
Keyword(s):  
Cancer Patients ◽  
Immune Status ◽  
Review Article ◽  
Care Plan ◽  
Patients With Cancer ◽  
Corona Virus ◽  
Cancer Review ◽  
Ideal System ◽  
Lethal Infection ◽  
Set Up

The episode of Covid19 (CORONA VIRUS) has become one of the greatest worldwide dangers around the world, which has now tainted over 1.7 million individuals with deaths of over 100,000 lives far & wide. Under these extraordinary conditions, there are no entrenched rules for cancer patients. The danger for genuine infection & passing in CORONA VIRUS cases increments with propelling age & existing co-morbid medical issue. After the rise of primary suspects in China during last month of 2019, enormous exploration endeavors have been in progress to comprehend the instruments of infectivity & contagiousness of coronavirus, a lethal infection liable for wretched endurance results. To limit the death rate, it gets judicious to distinguish indications quickly & utilize medicines suitably. Despite the fact that no fix has been set up, different clinical preliminaries are in progress to decide the most ideal system. Overseeing patients with cancer in these conditions is a fair task, considering their weak immune status & their ill health. Through this thorough audit, we talk about the effect of CORONA VIRUS on wellbeing & the immune system of who are infected, assessing the most recent care plan draws near & progressing clinical preliminaries. Also, we talk about difficulties confronted while treating cancer patients & propose possible ways to deal with these weak populace during pandemic.

scholarly journals The Association of Sources of Support, Types of Support and Satisfaction with Support Received on Perceived Stress and Quality of Life of Cancer Patients

2021 ◽  
Vol 20 ◽  
pp. 153473542199490
Author(s):  
Iván Ruiz-Rodríguez ◽  
Isabel Hombrados-Mendieta ◽  
Anabel Melguizo-Garín ◽  
Mª José Martos-Méndez
Keyword(s):  
Quality Of Life ◽  
Social Support ◽  
Cancer Patients ◽  
Perceived Stress ◽  
Emotional Support ◽  
Multidimensional Analysis ◽  
Informational Support ◽  
Cancer Data ◽  
The Family

Introduction: The aim of the present study is to carry out a multidimensional analysis of the relationship of social support with quality of life and the stress perceived by cancer patients. Methods: The participants were 200 patients with cancer. Data was gathered on sociodemographic characteristics, health, quality of life, social support and perceived stress. Results: Frequency of and satisfaction with different sources and types of support are related positively with improvement of quality of life and negatively with perceived stress. The emotional support from the partner and the emotional and informational support from the family are significant predictors of quality of life. Emotional support from the family reduces patients’ perceived stress. Satisfaction with emotional support from the partner and with the informational support from friends and family increases quality of life. Satisfaction with emotional support from the family and with informational support from friends decreases patients’ perceived stress. Instrumental support and support provided by health professionals are not good predictors of quality of life and perceived stress. Satisfaction with the support received is more significantly related with quality of life and stress than the frequency with which the sources provide support. Conclusions: These results have important practical implications to improve cancer patients’ quality of life and reduce their perceived stress through social support. Designing intervention strategies to improve satisfaction with the support provided to patients by their closest networks results in a global benefit for the patient’s quality of life.

scholarly journals The trends of complementary alternative medicine use among cancer patients

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Abdul Rahman Jazieh ◽  
Khadega A. Abuelgasim ◽  
Husam I. Ardah ◽  
Mohammad Alkaiyat ◽  
Omar B. Da’ar
Keyword(s):  
Alternative Medicine ◽  
Cancer Patients ◽  
Clinical Information ◽  
Cross Sectional Study ◽  
Complementary Alternative Medicine ◽  
Cultural Changes ◽  
Cross Sectional ◽  
Patients With Cancer ◽  
Cam Use ◽  
The Individual

Abstract Background The use of complementary and alternative medicine (CAM) is common among cancer patients and it may reflect the individual and societal beliefs on cancer therapy. Our study aimed to evaluate the trends of CAM use among patients with cancer between 2006 and 2018. Methods We included 2 Cohorts of patients with cancer who were recruited for Cohort 1 between 2006 and 2008 and for Cohort 2 between 2016 and 2018. The study is a cross-sectional study obtaining demographic and clinical information and inquiring about the types of CAM used, the reasons to use them and the perceived benefits. We compared the changes in the patterns of CAM use and other variables between the two cohorts. Results A total of 1416 patients were included in the study, with 464 patients in Cohort 1 and 952 patients in Cohort 2. Patients in Cohort 2 used less CAM (78.9%) than Cohort 1 (96.8%). Cohort 1 was more likely to use CAM to treat cancer compared to Cohort 2 (84.4% vs. 73%, respectively, p < 0.0001,); while Cohort 2 used CAM for symptom management such as pain control and improving appetite among others. Disclosure of CAM use did not change significantly over time and remains low (31.6% in Cohort 1 and 35.7% for Cohort 2). However, physicians were more likely to express an opposing opinion against CAM use in Cohort 2 compared to Cohort 1 (48.7% vs. 19.1%, p < 0.001, respectively). Conclusion There is a significant change in CAM use among cancer patients over the decade, which reflects major societal and cultural changes in this population. Further studies and interventions are needed to improve the disclosure to physicians and to improve other aspects of care to these patients.

Sign in / Sign up

Export Citation Format

Share Document